Abstract
Rsf-1 (HBXAP) has been reported as an amplified gene in human cancer, including the highly aggressive ovarian serous carcinoma. Rsf-1 protein interacts with SNF2H to form an ISWI chromatin remodeling complex, RSF. In this study, we investigated the functional role of Rsf-1 by observing phenotypes after expressing it in nontransformed cells. Acute expression of Rsf-1 resulted in DNA damage as evidenced by DNA strand breaks, nuclear γH2AX foci, and activation of the ATM-CHK2-p53-p21 pathway, leading to growth arrest and apoptosis. Deletion mutation and gene knockdown assays revealed that formation of a functional RSF complex with SNF2H was required for Rsf-1 to trigger DNA damage response (DDR). Gene knock-out of TP53 alleles, TP53 mutation, or treatment with an ATM inhibitor abolished up-regulation of p53 and p21 and prevented Rsf-1-induced growth arrest. Chronic induction of Rsf-1 expression resulted in chromosomal aberration and clonal selection for cells with c-myc amplification and CDKN2A/B deletion. Co-culture assays indicated Rsf-1-induced DDR as a selecting barrier that favored outgrowth of cell clones with a TP53 mutation. The above findings suggest that increased Rsf-1 expression and thus excessive RSF activity, which occurs in tumors harboring Rsf-1 amplification, can induce chromosomal instability likely through DDR.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adenosine Triphosphatases / genetics
-
Adenosine Triphosphatases / metabolism
-
Apoptosis / genetics
-
Ataxia Telangiectasia Mutated Proteins
-
Cell Cycle Proteins / genetics
-
Cell Cycle Proteins / metabolism
-
Cell Line
-
Checkpoint Kinase 2
-
Chromosomal Proteins, Non-Histone / genetics
-
Chromosomal Proteins, Non-Histone / metabolism
-
Chromosome Aberrations
-
Cyclin-Dependent Kinase Inhibitor p16 / genetics
-
Cyclin-Dependent Kinase Inhibitor p16 / metabolism
-
Cyclin-Dependent Kinase Inhibitor p21 / genetics
-
Cyclin-Dependent Kinase Inhibitor p21 / metabolism
-
DNA Damage*
-
DNA-Binding Proteins / genetics
-
DNA-Binding Proteins / metabolism
-
Gene Knockdown Techniques
-
Genomic Instability*
-
Humans
-
Mutation
-
Nuclear Proteins / genetics
-
Nuclear Proteins / metabolism*
-
Protein Serine-Threonine Kinases / genetics
-
Protein Serine-Threonine Kinases / metabolism
-
Trans-Activators / genetics
-
Trans-Activators / metabolism*
-
Tumor Suppressor Protein p53 / genetics
-
Tumor Suppressor Protein p53 / metabolism
-
Tumor Suppressor Proteins / genetics
-
Tumor Suppressor Proteins / metabolism
Substances
-
CDKN1A protein, human
-
Cell Cycle Proteins
-
Chromosomal Proteins, Non-Histone
-
Cyclin-Dependent Kinase Inhibitor p16
-
Cyclin-Dependent Kinase Inhibitor p21
-
DNA-Binding Proteins
-
Nuclear Proteins
-
RSF1 protein, human
-
TP53 protein, human
-
Trans-Activators
-
Tumor Suppressor Protein p53
-
Tumor Suppressor Proteins
-
Checkpoint Kinase 2
-
ATM protein, human
-
Ataxia Telangiectasia Mutated Proteins
-
CHEK2 protein, human
-
Protein Serine-Threonine Kinases
-
Adenosine Triphosphatases
-
SMARCA5 protein, human